13F Filings History of Hillman Capital Management, Inc.

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$172M
Signature - Title
Mark A. Hillman - CEO
Location
Bethesda, MD
Summary
This page shows a list of all the recent 13F filings made by Hillman Capital Management, Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Hillman Capital Management, Inc. reported 53 stock holdings with total value $172M as of Q3 2025. Top holdings included ASML, WBD, EL, CVS, and BA.

Notify me when Hillman Capital Management, Inc. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 53 $172M +$17.4M -$35.6M -$18.2M ASML, WBD, EL, CVS, BA 13F-HR 14 Nov 2025, 09:00
Q2 2025 50 $183M +$4.26M -$26.9M -$22.6M T, WBD, BA, EL, MSFT 13F-HR 14 Aug 2025, 09:00
Q1 2025 51 $203M +$16.4M -$78.8M -$62.4M T, WBD, CVS, ZBH, KMX 13F-HR 15 May 2025, 09:00
Q4 2024 54 $270M +$37.8M -$44.9M -$7.13M AMZN, T, BA, WBD, KMX 13F-HR 14 Feb 2025, 09:00
Q3 2024 52 $292M +$18.1M -$19.2M -$1.09M IFF, MSFT, T, DD, SPG 13F-HR 14 Nov 2024, 09:00
Q2 2024 53 $283M +$20.1M -$31M -$10.9M MSFT, AMZN, IFF, WFC, SPG 13F-HR 14 Aug 2024, 09:00
Q1 2024 52 $311M +$34.9M -$28.5M +$6.46M TSM, MSFT, WFC, AMZN, KMX 13F-HR 15 May 2024, 09:00
Q4 2023 53 $290M +$23.3M -$29M -$5.7M SPG, MSFT, ASML, BA, INTC 13F-HR 14 Feb 2024, 09:00
Q3 2023 53 $260M +$25.2M -$33.7M -$8.53M MSFT, BIIB, WFC, IFF, GSK 13F-HR 14 Nov 2023, 09:00
Q2 2023 55 $283M +$13.4M -$5.12M +$8.23M MSFT, AMZN, TSM, ASML, WFC 13F-HR 14 Aug 2023, 09:00
Q1 2023 52 $264M +$6.47M -$15.9M -$9.47M BUD, MSFT, TSM, ASML, EPD 13F-HR 15 May 2023, 09:00
Q4 2022 52 $255M +$10.2M -$22.4M -$12.2M BUD, WFC, KHC, BA, CVS 13F-HR 14 Feb 2023, 09:00
Q3 2022 48 $241M +$25.1M -$30.8M -$5.67M CVS, WFC, MSFT, BIIB, K 13F-HR 14 Nov 2022, 09:00
Q2 2022 48 $275M +$33.6M -$23.6M +$10M K, T, KHC, GSK, MSFT 13F-HR 15 Aug 2022, 08:01
Q1 2022 48 $315M +$51M -$27.6M +$23.4M KHC, GSK, K, BMY, AMZN 13F-HR 16 May 2022, 09:28
Q4 2021 54 $291M +$17.4M -$17.2M +$157K SPG, CVS, WFC, MSFT, GSK 13F-HR 14 Feb 2022, 08:53
Q3 2021 51 $285M +$44.4M -$11.5M +$32.9M WFC, SPG, BA, KHC, AMZN 13F-HR 15 Nov 2021, 09:21
Q2 2021 48 $263M +$18M -$305K +$17.7M WFC, AMZN, XOM, SPG, PAA 13F-HR 16 Aug 2021, 09:11
Q1 2021 43 $228M +$59.8M -$35.7M +$24.1M WFC, XOM, K, KHC, BA 13F-HR 14 May 2021, 08:49
Q4 2020 46 $185M +$20M -$4.42M +$15.6M JWN, DD, MSFT, WFC, KHC 13F-HR 12 Feb 2021, 08:33
Q3 2020 36 $142M +$22M -$16.1M +$5.93M MSFT, INTC, CMP, BIIB, DD 13F-HR 09 Nov 2020, 11:45
Q2 2020 38 $137M +$21.9M -$5M +$16.9M AMZN, MSFT, DD, KHC, K 13F-HR 04 Aug 2020, 10:57
Q1 2020 36 $104M +$13.7M -$15.8M -$2.12M AMZN, BIIB, MSFT, BMY, K 13F-HR 29 Apr 2020, 16:07
Q4 2019 50 $141M $0 $0 JWN, MSFT, BMY, BIIB, T 13F-HR 14 Feb 2020, 10:44
Q4 2013 38 $66.9M $0 $0 RTN, AXP, BAC, AAPL, GS 13F-HR 07 Feb 2014, 13:16